Ondansetron for prevention of intrathecal opioids-induced pruritus, nausea and vomiting after cesarean delivery.
Charuluxananan
Somrat
S
Department of Anesthesiology Faculty of Medicine Chulalongkorn University King Chulalongkorn Memorial Hospital Pathumwan, Bangkok Thailand.
Kyokong
Oranuch
O
Somboonviboon
Wanna
W
Narasethakamol
Arunchai
A
Promlok
Pissamai
P
D000328:Adult; D000701:Analgesics, Opioid / Q000009:adverse effects*; D000932:Antiemetics / Q000627:therapeutic use*; D002585:Cesarean Section; D005260:Female; D006801:Humans; D009020:Morphine / Q000009:adverse effects; D017294:Ondansetron / Q000627:therapeutic use*; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D011247:Pregnancy; D011537:Pruritus / Q000139:chemically induced* / Q000517:prevention & control*; D017409:Sufentanil / Q000009:adverse effects
D000701:Analgesics, Opioid; D000932:Antiemetics; D017294:Ondansetron; D009020:Morphine; D017409:Sufentanil